| Title |
Sulpiride versus placebo for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2014
|
| DOI | 10.1002/14651858.cd007811.pub2 |
| Pubmed ID | |
| Authors |
Jijun Wang, Stephanie Sampson |
| Abstract |
Sulpiride is a relatively old antipsychotic drug reputed to have a low incidence of adverse effects and an effect on the negative symptoms of schizophrenia. This relatively inexpensive antipsychotic drug has a similar neuropharmacological profile to several novel atypical drugs. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 14% |
| Colombia | 1 | 14% |
| United Kingdom | 1 | 14% |
| Unknown | 4 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 176 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 28 | 16% |
| Student > Ph. D. Student | 20 | 11% |
| Student > Bachelor | 19 | 11% |
| Researcher | 18 | 10% |
| Student > Doctoral Student | 10 | 6% |
| Other | 26 | 15% |
| Unknown | 57 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 25% |
| Psychology | 21 | 12% |
| Nursing and Health Professions | 18 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Social Sciences | 7 | 4% |
| Other | 14 | 8% |
| Unknown | 65 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2019.
All research outputs
#5,471,255
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#7,375
of 11,499 outputs
Outputs of similar age
#50,593
of 240,030 outputs
Outputs of similar age from Cochrane database of systematic reviews
#141
of 217 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,030 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 217 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.